Buy or sell Joyn Bio stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Joyn Bio Stock

A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.

Headquarters

Boston MA, US

Total Funding

$100M

About Joyn Bio Stock

Joyn Bio is a joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants to provide growers with next generation solutions to their biggest challenges. Joyn Bio’s first area of focus will be on engineering microbes that provide cereal crops with their nitrogen needs to reduce agriculture’s reliance on nitrogen fertilizer and its environmental impact. Joyn Bio brings together microbiologists, synthetic biologists, plant scientists, and ecologists at its headquarters in Boston, Massachusetts and its plant research facility in West Sacramento, California.

Funding History

March 2018$100M

Management

Co-Founder

Jason Kelly

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Joyn Bio or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo